一纸百亿美元收购协议背后,全球制药巨头们正为即将坠落的“专利悬崖”竞速寻找救命绳索。默沙东(Merck)2025年7月9日宣布以每股107美元的价格全现金收购维罗纳制药(Verona Pharma),总估值达100亿美元。这一报价较维罗纳周二收盘价溢价23%,成为默沙东自2023年以108亿美元收购Prometheus Biosciences以来最大的一笔收购案。维罗纳股价应声暴涨20%,而这家...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.